- Thirty patients with fibrocystic breast disease received a clinical trial of danazol. Twenty-three patients had a 5 to 6-month treatment regime.

- Partial or complete relief of breast pain and nodularity for all patients included in the clinical trial.
- The researchers found malignancy in one patient following three months of therapy. There were limited reported side effects.
- Recurrence of symptoms occurred after discontinuation of the drug.

- A study currently being performed in Japan will assess the efficacy and safety of the Xiaoru Sanjie capsule in the treatment of cyclo-mastopathy. The study will be a multicenter, randomized, open controlled clinical study.